New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 18 04:00PM ET
123.67
Dollar change
+3.16
Percentage change
2.62
%
IndexS&P 500 P/E15.49 EPS (ttm)7.98 Insider Own0.67% Shs Outstand1.74B Perf Week-6.32%
Market Cap215.17B Forward P/E21.77 EPS next Y5.68 Insider Trans-4.89% Shs Float1.73B Perf Month-6.51%
Enterprise Value221.82B PEG1.49 EPS next Q1.31 Inst Own79.93% Short Float1.12% Perf Quarter-4.65%
Income13.91B P/S4.99 EPS this Y10.36% Inst Trans2.41% Short Ratio3.01 Perf Half Y11.31%
Sales43.11B P/B4.41 EPS next Y10.25% ROA17.45% Short Interest19.43M Perf YTD9.34%
Book/sh28.05 P/C31.44 EPS next 5Y10.42% ROE30.66% 52W High141.23 -12.43% Perf Year20.40%
Cash/sh3.93 P/FCF32.32 EPS past 3/5Y24.73% 29.98% ROIC22.61% 52W Low99.71 24.03% Perf 3Y16.44%
Dividend Est.2.40 (1.94%) EV/EBITDA21.43 Sales past 3/5Y-0.88% 5.63% Gross Margin58.40% Volatility2.69% 2.08% Perf 5Y32.85%
Dividend TTM2.32 (1.88%) EV/Sales5.15 EPS Y/Y TTM139.98% Oper. Margin17.62% ATR (14)3.18 Perf 10Y147.69%
Dividend Ex-DateJul 15, 2025 Quick Ratio1.27 Sales Y/Y TTM5.85% Profit Margin32.28% RSI (14)31.91 Recom1.90
Dividend Gr. 3/5Y7.17% 11.16% Current Ratio1.78 EPS Q/Q37.19% SMA20-6.87% Beta0.71 Target Price143.17
Payout29.33% Debt/Eq0.27 Sales Q/Q7.37% SMA50-7.07% Rel Volume3.03 Prev Close120.51
Employees114000 LT Debt/Eq0.26 EarningsJul 17 BMO SMA200-1.19% Avg Volume6.45M Price123.67
IPOMar 01, 1937 Option/ShortYes / Yes EPS/Sales Surpr.0.33% 0.45% Trades Volume19,570,105 Change2.62%
Date Action Analyst Rating Change Price Target Change
Jul-18-25Upgrade Jefferies Hold → Buy $145
Jun-16-25Initiated Leerink Partners Market Perform $143
Oct-08-24Initiated Oppenheimer Outperform $130
Sep-19-24Initiated Piper Sandler Overweight $131
Jul-30-24Downgrade Edward Jones Buy → Hold
May-30-24Initiated Goldman Buy $121
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Apr-20-23Reiterated UBS Buy $117 → $130
Jul-18-25 09:14PM
12:34PM
11:01AM
09:47AM
09:40AM
09:38AM Loading…
09:38AM
09:35AM
09:03AM
03:08AM
01:31AM
Jul-17-25 08:08PM
08:07PM
04:38PM
04:10PM
02:43PM
01:21PM Loading…
01:21PM
12:59PM
11:29AM
11:13AM
11:06AM
10:48AM
10:11AM
09:30AM
08:52AM
08:40AM
08:16AM
08:13AM
08:05AM
07:44AM
07:37AM
07:33AM Loading…
07:33AM
07:30AM
06:05AM
05:08AM
03:46AM
Jul-16-25 07:00PM
06:02PM
05:45PM
04:48PM
11:40AM
09:52AM
08:19AM
04:07AM
03:43AM
03:43AM
12:09AM
Jul-15-25 11:03PM
05:52PM
04:55PM
09:02AM
08:45AM
Jul-14-25 04:45PM
09:15AM
08:29AM
04:17AM
Jul-13-25 07:51AM
Jul-12-25 06:40AM
Jul-11-25 07:10PM
06:00PM
09:46AM
Jul-10-25 04:25PM
10:00AM
08:21AM
08:18AM
07:28AM
Jul-09-25 09:09AM
08:50AM
08:29AM
04:43AM
01:30AM
Jul-08-25 08:31AM
08:00AM
Jul-07-25 08:17AM
08:00AM
Jul-06-25 08:45AM
Jul-04-25 09:30AM
04:01AM
02:43AM
Jul-03-25 08:50AM
Jul-02-25 06:00PM
12:00PM
10:01AM
09:40AM
09:35AM
09:00AM
Jul-01-25 04:42PM
02:41PM
12:26PM
09:00AM
07:01AM
Jun-30-25 06:46AM
06:22AM
Jun-28-25 05:49AM
01:27AM
Jun-26-25 06:00PM
01:26PM
11:40AM
09:00AM
08:45AM
Jun-25-25 03:08PM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blount Sally E.DirectorApr 30 '25Sale129.662,600337,11634,058May 02 05:04 PM
SALLY E BLOUNTDirectorApr 30 '25Proposed Sale129.662,600337,116Apr 30 04:23 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Option Exercise80.9891,1677,382,704163,095Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Option Exercise80.9820016,19672,128Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Sale133.8291,16712,199,96871,928Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Sale136.6520027,32971,928Mar 07 06:55 PM
Lisa D. EarnhardtOfficerMar 07 '25Proposed Sale136.6520027,329Mar 07 06:28 PM
Lisa D. EarnhardtOfficerMar 06 '25Proposed Sale133.8291,16712,199,967Mar 06 05:47 PM
Wainer Andrea FRETIRED EVPMar 03 '25Sale138.17949131,12374,381Mar 04 08:05 PM
Shroff EricSenior Vice PresidentMar 03 '25Sale138.1756277,65231,970Mar 04 08:00 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTMar 03 '25Sale138.171,111153,50766,878Mar 04 07:49 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 03 '25Sale138.17791109,29295,583Mar 04 07:44 PM
MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLERMar 03 '25Sale138.1756277,65221,061Mar 04 07:39 PM
Eric ShroffOfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 08:40 PM
Andrea F. WainerRetired OfficerMar 03 '25Proposed Sale138.17949131,123Mar 03 08:18 PM
Louis H. MorroneOfficerMar 03 '25Proposed Sale138.171,111153,506Mar 03 08:08 PM
Mary K. MorelandOfficerMar 03 '25Proposed Sale138.17791109,292Mar 03 07:58 PM
John A. McCoy, Jr.OfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 07:52 PM
Ford Robert BCHAIRMAN AND CEOFeb 05 '25Option Exercise38.40285,38810,958,899505,447Feb 07 05:51 PM
Ford Robert BCHAIRMAN AND CEOFeb 05 '25Sale131.17285,38837,435,200220,059Feb 07 05:51 PM
Robert B. FordOfficerFeb 05 '25Proposed Sale131.17285,38837,435,238Feb 05 06:52 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 29 '25Option Exercise38.40131,3605,044,224316,166Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 30 '25Option Exercise38.4058,4282,243,635243,234Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 29 '25Sale128.35131,36016,859,675184,806Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 30 '25Sale128.0758,4287,482,629184,806Jan 31 07:16 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTJan 30 '25Option Exercise38.4023,771912,806149,468Jan 31 07:08 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTJan 30 '25Sale128.5023,7713,054,574125,697Jan 31 07:08 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTJan 28 '25Sale127.392,644336,8190Jan 30 07:33 PM
Hubert L. AllenOfficerJan 30 '25Proposed Sale128.0758,4287,482,628Jan 30 05:33 PM
Daniel Gesua Sive SalvadoriOfficerJan 30 '25Proposed Sale128.5023,7713,054,573Jan 30 05:26 PM
Hubert L. AllenOfficerJan 29 '25Proposed Sale128.35131,36016,859,675Jan 29 05:30 PM
Funck, Jr. Robert E.OfficerNov 04 '24Proposed Sale120.0015,0001,800,000Nov 04 04:02 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTOct 21 '24Option Exercise47.00157,4217,398,787342,227Oct 23 05:10 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTOct 21 '24Sale117.04157,42118,424,298184,806Oct 23 05:10 PM
ALLEN HUBERT LOfficerOct 21 '24Proposed Sale118.89157,42118,715,783Oct 21 04:08 PM
Ford Robert BCHAIRMAN AND CEOSep 12 '24Option Exercise47.19141,6796,685,975361,738Sep 13 05:24 PM
Ford Robert BCHAIRMAN AND CEOSep 12 '24Sale116.41141,67916,493,218220,059Sep 13 05:24 PM
Robert B. FordOfficerSep 12 '24Proposed Sale116.41141,67916,492,852Sep 12 06:20 PM
MCCOY JOHN A. JR.VICE PRESIDENTSep 04 '24Sale114.83273,10018,681Sep 04 07:52 PM
Funck, Jr. Robert E.OfficerSep 04 '24Proposed Sale115.0030,0003,450,000Sep 04 04:04 PM